High functioning investigator sites are essential to the delivery of a successful clinical trial. But not all sites seem able to fulfil...
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.










